Category icon
Hypertension and Diabetes Mellitus

Gurushankar Govindarajan, James R Sowers, Craig S Stump,

Category icon
The New Era in AF Screening at Home

Bernd Sanner, Keitaro Senoo, Faizel Osman

Category icon
Hypertension and Stroke: Update on Treatment

Mauricio Wajngarten, Gisele Sampaio Silva,

Category icon
Syncope in the Elderly

Helen O’Brien, Rose Anne Kenny,

Category icon
Home Blood Pressure Monitoring

Jacob George, Thomas M MacDonald,

Category icon
Clinical Diagnosis and Management of Resistant Hypertension

Costas P Tsioufis, Alexandros Kasiakogias, Dimitris Tousoulis,

Category icon
Baroreflex Sensitivity Assessment - Latest Advances and Strategies

Maria Teresa La Rovere, Roberto Maestri, Gian Domenico Pinna,

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Related Articles

Articles

Guest Editorial: Challenges in Resistant Hypertension

Thomas Kahan,

Citation: European Cardiology Review 2016;11(1):18–9

Clinical Diagnosis and Management of Resistant Hypertension

Costas P Tsioufis, Alexandros Kasiakogias, Dimitris Tousoulis,

Citation: European Cardiology Review 2016;11(1):12–7

A Practical Clinical Approach to the Diagnosis and Treatment of Patients…

Brendan P Madden,

Citation: European Cardiology Review 2015;10(2):102–7

Foreword

Juan Carlos Kaski,

Citation: European Cardiology Review 2015;10(2):73